Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
31.5M
-
Shares change
-
+926K
-
Total reported value, excl. options
-
$168M
-
Value change
-
-$6.99M
-
Number of buys
-
48
-
Number of sells
-
-37
-
Price
-
$5.34
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) as of Q1 2022
106 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.5M shares
of 86.3M outstanding shares and own 36.45% of the company stock.
Largest 10 shareholders include FMR LLC (4.42M shares), Column Group LLC (3.57M shares), EcoR1 Capital, LLC (3.42M shares), ORBIMED ADVISORS LLC (2.09M shares), FIRST MANHATTAN CO (1.96M shares), ALKEON CAPITAL MANAGEMENT LLC (1.91M shares), VANGUARD GROUP INC (1.64M shares), ArrowMark Colorado Holdings LLC (1.28M shares), BOXER CAPITAL, LLC (1.05M shares), and Invus Financial Advisors, LLC (1.01M shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.